Navigation Links
A Likely Use For Estrogen Therapy

A new study shows that estrogen therapy does not decrease, but may increase, the risk for dementia in postmenopausal women, say researchers //.Previous studies have reported an association between postmenopausal estrogen use and lower risk of dementia.

A placebo-controlled trial of estrogen or estrogen plus progestin in women aged 65 to 79 years looked at associated risk for dementia. In the estrogen-only trial, researchers found 47 participants were diagnosed with probable dementia, of whom 28 were assigned to receive estrogen. During follow-up, the incidence of dementia was 49-percent higher among women receiving estrogen only compared to those receiving placebo. Similar results were found in the estrogen-plus-progestin trial. Researchers say these findings showed only slightly lower-than-average cognitive function, but when data from the two trials were pooled, the overall risk for probable dementia was significantly increased by 76 percent.

Thus researchers conclude that the use of hormone therapy to prevent dementia or [mild cognitive impairment] in women 65 years of age or older is not recommended and they say that more research is required to confirm their findings.
'"/>




Page: 1

Related medicine news :

1. Likely reason which makes analgesics work against Alzheimers
2. Homeless More Likely to Die Early
3. Blood Transfusion A Likely Cause For A Rare And Fatal Brain Disorder
4. Sleep Disorder,The Likely Cause Of Most Road Accidents
5. Premature Babies More Likely If Women Have Higher Protein Albumin In Urine
6. Women Less Likely To Conceive Post-Caesarean
7. Obesity More Likely to Cause Disability than Death in Elderly
8. A Likely Breakthrough For Prostate Cancer Patients
9. Bird Flu Likely To Reduce World Energy Demand
10. Men More Likely To Lose Teeth To Periodontal Disease
11. Women Who Smoke Are More Likely To Get Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: